Genetic counselling and testing for inherited gene mutations in newly diagnosed patients with breast cancer: a review of the existing literature and a proposed research agenda (Q37131303)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Genetic counselling and testing for inherited gene mutations in newly diagnosed patients with breast cancer: a review of the existing literature and a proposed research agenda	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

18 August 2017

2 references

19 November 2020

29 July 2022

Genetic counselling and testing for inherited gene mutations in newly diagnosed patients with breast cancer: a review of the existing literature and a proposed research agenda (English)

1 reference

Europe PubMed Central

18 August 2017

0 references

breast neoplasm

2 references

19 November 2020

29 July 2022

genetic counseling

1 reference

22 July 2019

genetic predisposition to disease

1 reference

10 September 2020

1 reference

6 November 2020

genetic testing

1 reference

19 November 2020

1 reference

research agenda

1 reference

based on heuristic

inferred from title

1

object named as

Bettina Meiser

1 reference

Europe PubMed Central

18 August 2017

Kristine Barlow-Stewart

4

object named as

Kristine Barlow-Stewart

1 reference

Europe PubMed Central

18 August 2017

author name string

Kathy Tucker

2

1 reference

Europe PubMed Central

18 August 2017

Michael Friedlander

3

1 reference

Europe PubMed Central

18 August 2017

Elizabeth Lobb

5

1 reference

Europe PubMed Central

18 August 2017

Christobel Saunders

6

1 reference

Europe PubMed Central

18 August 2017

Gillian Mitchell

7

1 reference

Europe PubMed Central

18 August 2017

publication date

28 November 2008

14 references

Europe PubMed Central

18 August 2017

13 March 2019

3 April 2019

20 June 2019

17 June 2019

30 June 2019

22 July 2019

14 September 2019

19 September 2019

23 July 2020

10 September 2020

6 November 2020

19 November 2020

29 July 2022

Breast Cancer Research

13 references

Europe PubMed Central

18 August 2017

13 March 2019

3 April 2019

20 June 2019

17 June 2019

30 June 2019

22 July 2019

14 September 2019

19 September 2019

23 July 2020

6 November 2020

19 November 2020

29 July 2022

10

1 reference

Europe PubMed Central

18 August 2017

6

1 reference

Europe PubMed Central

18 August 2017

216

1 reference

Europe PubMed Central

18 August 2017

https://scigraph.springernature.com/pub.10.1186/bcr2194

0 references

Trends in mastectomy rates at the Mayo Clinic Rochester: effect of surgical year and preoperative magnetic resonance imaging

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2656887

14 September 2017

Clinical and pathologic characteristics of patients with BRCA-positive and BRCA-negative breast cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2656887

14 September 2017

BRCA1 mutations in Algerian breast cancer patients: high frequency in young, sporadic cases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2656887

14 September 2017

Breast cancer risk associated with BRCA1 and BRCA2 in diverse populations

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2656887

14 September 2017

Increasing use of contralateral prophylactic mastectomy for breast cancer patients: a trend toward more aggressive surgical treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2656887

14 September 2017

BRCA1/2 mutation testing in breast cancer patients: a prospective study of the long-term psychological impact of approach during adjuvant radiotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2656887

14 September 2017

Selective induction of chemotherapy resistance of mammary tumors in a conditional mouse model for hereditary breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2656887

14 September 2017

Hereditary breast cancer: pathobiology, clinical translation, and potential for targeted cancer therapeutics

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2656887

14 September 2017

Prophylactic mastectomy in BRCA1/2 mutation carriers and women at risk of hereditary breast cancer: long-term experiences at the Rotterdam Family Cancer Clinic

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2656887

14 September 2017

Diagnostic accuracy of methods for the detection of BRCA1 and BRCA2 mutations: a systematic review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2656887

14 September 2017

Predictors and outcomes of contralateral prophylactic mastectomy among breast cancer survivors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2656887

14 September 2017

Clinical management of BRCA1 and BRCA2 mutation carriers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2656887

14 September 2017

PARP-1 inhibitors: are they the long-sought genetically specific drugs for BRCA1/2-associated breast cancers?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2656887

14 September 2017

A comparison of letrozole and tamoxifen in postmenopausal women with early breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2656887

14 September 2017

Risk reduction of contralateral breast cancer and survival after contralateral prophylactic mastectomy in BRCA1 or BRCA2 mutation carriers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2656887

14 September 2017

Racial differences in the incidence of BRCA1 and BRCA2 mutations in a cohort of early onset breast cancer patients: African American compared to white women

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2656887

14 September 2017

Psychological impact of genetic testing for cancer susceptibility: an update of the literature

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2656887

14 September 2017

Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2656887

14 September 2017

Efficacy of prophylactic mastectomy in women with unilateral breast cancer: a cancer research network project

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2656887

14 September 2017

Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2656887

14 September 2017

Initial experience with surgical treatment planning in the newly diagnosed breast cancer patient at high risk for BRCA-1 or BRCA-2 mutation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2656887

14 September 2017

Contralateral prophylactic mastectomy. Predictors of significant histologic findings

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2656887

14 September 2017

Contralateral breast cancer in BRCA1 and BRCA2 mutation carriers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2656887

14 September 2017

Effect of genetic cancer risk assessment on surgical decisions at breast cancer diagnosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2656887

14 September 2017

Cancer incidence in relatives of a population-based set of cases of early-onset breast cancer with a known BRCA1 and BRCA2 mutation status

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2656887

14 September 2017

American Society of Clinical Oncology Policy Statement Update: Genetic Testing for Cancer Susceptibility

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2656887

14 September 2017

Novel mutations in the BRCA1 and BRCA2 genes in Iranian women with early-onset breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2656887

14 September 2017

Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2656887

14 September 2017

Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2656887

14 September 2017

Decision aids for people facing health treatment or screening decisions

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2656887

14 September 2017

BRCA1 mutations and other sequence variants in a population-based sample of Australian women with breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2656887

14 September 2017

BRCA1 mutations and breast cancer in the general population: analyses in women before age 35 years and in women before age 45 years with first-degree family history

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2656887

14 September 2017

The founder mutations 185delAG and 5382insC in BRCA1 and 6174delT in BRCA2 appear in 60% of ovarian cancer and 30% of early-onset breast cancer patients among Ashkenazi women

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2656887

14 September 2017

Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2656887

14 September 2017

Barriers to participating in genetic counseling and BRCA testing during primary treatment for breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2656887

14 September 2017

Attitudes of genetic clinicians in Wales to the future development of cancer genetics services

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2656887

14 September 2017

Too much, too soon? Patients and health professionals' views concerning the impact of genetic testing at the time of breast cancer diagnosis in women under the age of 40.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2656887

14 September 2017

Cancer patients who experienced diagnostic genetic testing for cancer susceptibility: reactions and behavior after the disclosure of a positive test result.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2656887

14 September 2017

Expression of BRCA1 protein in breast cancer and its prognostic significance

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2656887

27 June 2018

A randomized trial of a breast/ovarian cancer genetic testing decision aid used as a communication aid during genetic counseling

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2656887

3 September 2018

Predictors of contralateral prophylactic mastectomy in women with a BRCA1 or BRCA2 mutation: the Hereditary Breast Cancer Clinical Study Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2656887

3 September 2018

BRCA1 mRNA expression levels predict for overall survival in ovarian cancer after chemotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2656887

3 September 2018

Genetic counseling and clinical management of newly diagnosed breast cancer patients at genetic risk for BRCA germline mutations: perspective of a surgical oncologist.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2656887

3 September 2018

Clinical outcomes of breast cancer in carriers of BRCA1 and BRCA2 mutations

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2656887

3 September 2018

A randomized controlled trial of a decision aid for women considering genetic testing for breast and ovarian cancer risk.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2656887

3 September 2018

BRCA1-positive breast cancers in young women from Poland.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2656887

3 September 2018

Breast cancer risk following bilateral oophorectomy in BRCA1 and BRCA2 mutation carriers: an international case-control study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2656887

3 September 2018

Surgical decisions made by 158 women with hereditary breast cancer aged <50 years.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2656887

3 September 2018

BRCA1 testing with definitive results: a prospective study of psychological distress in a large clinic-based sample

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2656887

3 September 2018

Incidence of BRCA1 and BRCA2 mutations in young Korean breast cancer patients.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2656887

3 September 2018

Mutational analysis of BRCA1 and BRCA2 in Mediterranean Spanish women with early-onset breast cancer: identification of three novel pathogenic mutations

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2656887

3 September 2018

Prevalence of BRCA1 and BRCA2 germline mutations in young breast cancer patients: a population-based study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2656887

3 September 2018

Use of Genetic Testing and Prophylactic Mastectomy and Oophorectomy in Women With Breast or Ovarian Cancer From Families With a BRCA1 or BRCA2 Mutation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2656887

3 September 2018

The pathology of familial breast cancer: predictive value of immunohistochemical markers estrogen receptor, progesterone receptor, HER-2, and p53 in patients with mutations in BRCA1 and BRCA2.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2656887

3 September 2018

BRCA2 germline mutations among early onset breast cancer patients unselected for family history of the disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2656887

3 September 2018

BRCA-associated breast cancer in young women

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2656887

3 September 2018

Breast cancer mortality trends in Australia: 1921 to 1994.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2656887

3 September 2018

Anti-cytotoxic T-lymphocyte antigen-4 antibody: the first in an emerging class of immunomodulatory antibodies for cancer treatment

1 reference

https://api.crossref.org/works/10.1186%2FBCR2194

21 January 2018

BRCA1 Mutations and Breast Cancer in the General Population

1 reference

https://api.crossref.org/works/10.1186%2FBCR2194

21 January 2018

Surveillance for familial breast cancer: Differences in outcome according toBRCA mutation status

1 reference

https://api.crossref.org/works/10.1186%2FBCR2194

21 January 2018

Prediction of pathogenic mutations in patients with early-onset breast cancer by family history

1 reference

https://api.crossref.org/works/10.1186%2FBCR2194

21 January 2018

BRCA1, BRCA2 and TP53 mutations in very early-onset breast cancer with associated risks to relatives

1 reference

https://api.crossref.org/works/10.1186%2FBCR2194

21 January 2018

A paradox: urgent BRCA genetic testing

1 reference

https://api.crossref.org/works/10.1186%2FBCR2194

21 January 2018

Genetic epidemiology of BRCA mutations – family history detects less than 50% of the mutation carriers

1 reference

https://api.crossref.org/works/10.1186%2FBCR2194

21 January 2018

Impact of Genetic Testing for Breast–Ovarian Cancer Susceptibility

1 reference

https://api.crossref.org/works/10.1186%2FBCR2194

21 January 2018

Novel germline BRCA1 mutations detected in women in singapore who developed breast carcinoma before the age of 36 years

1 reference

https://pubmed.ncbi.nlm.nih.gov/19090970

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Differential Contributions ofBRCA1andBRCA2to Early-Onset Breast Cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/19090970

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tailoring breast cancer treatment to genetic status: the challenges ahead

1 reference

https://pubmed.ncbi.nlm.nih.gov/19090970

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Contribution of BRCA1 and BRCA2 germline mutations to the incidence of early-onset breast cancer in Cyprus

1 reference

https://pubmed.ncbi.nlm.nih.gov/19090970

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Frequency of BRCA1/BRCA2 mutations in a population-based sample of young breast carcinoma cases

1 reference

https://pubmed.ncbi.nlm.nih.gov/19090970

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Significantly lower rates of BRCA1/BRCA2 founder mutations in Ashkenazi women with sporadic compared with familial early onset breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/19090970

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Breast cancer risk after bilateral prophylactic oophorectomy in BRCA1 mutation carriers

1 reference

https://pubmed.ncbi.nlm.nih.gov/19090970

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Short term psychological distress in patients actively approached for genetic counselling after diagnosis of breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/19090970

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevalence and penetrance of BRCA1 and BRCA2 mutations in a population-based series of breast cancer cases. Anglian Breast Cancer Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/19090970

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy of contralateral prophylactic mastectomy in women with a personal and family history of breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/19090970

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevalence of BRCA1 and BRCA2 gene mutations in patients with early-onset breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/19090970

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Utilization of BRCA1/BRCA2 mutation testing in newly diagnosed breast cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/19090970

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Impact of BRCA1/2 testing and disclosure of a positive test result on women affected and unaffected with breast or ovarian cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/19090970

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ten-Year Multi-Institutional Results of Breast-Conserving Surgery and Radiotherapy inBRCA1/2-Associated Stage I/II Breast Cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/19090970

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Development of a communication aid to facilitate risk communication in consultations with unaffected women from high risk breast cancer families: a pilot study

1 reference

https://pubmed.ncbi.nlm.nih.gov/19090970

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Similar contributions of BRCA1 and BRCA2 germline mutations to early-onset breast cancer in Germany

1 reference

https://pubmed.ncbi.nlm.nih.gov/19090970

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Population-based estimate of the average age-specific cumulative risk of breast cancer for a defined set of protein-truncating mutations in BRCA1 and BRCA2. Australian Breast Cancer Family Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/19090970

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Contribution of BRCA1 and BRCA2 germ-line mutations to the incidence of breast cancer in young women: results from a prospective population-based study in France

1 reference

https://pubmed.ncbi.nlm.nih.gov/19090970

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

FounderBRCA1 andBRCA2 mutations in early-onset French Canadian breast cancer cases unselected for family history

1 reference

https://pubmed.ncbi.nlm.nih.gov/19090970

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Family history of breast and ovarian cancers and BRCA1 and BRCA2 mutations in a population-based series of early-onset breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/19090970

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quality of life after contralateral prophylactic mastectomy in newly diagnosed high-risk breast cancer patients who underwent BRCA1/2 gene testing

1 reference

https://pubmed.ncbi.nlm.nih.gov/19090970

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Impact of BRCA1/BRCA2 counseling and testing on newly diagnosed breast cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/19090970

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A prospective study on predictive factors linked to the presence of BRCA1 and BRCA2 mutations in breast cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/19090970

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/BCR2194

1 reference

Europe PubMed Central

18 August 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

18 August 2017

1 reference

Europe PubMed Central

18 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37131303&oldid=1947811202"